Notice Number: NOT-HL-19-686
Key Dates
Release Date: March 5, 2019
PAR-18-407
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants that renewal applications are not allowed to be submitted in response to PAR-18-407 "Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required). Language that refers to renewal applications has been revised.
Currently reads:
Part 1. Overview Information
Key Dates
Application Due Date(s)
New, Renewal and Revision Applications: February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019, by 5:00 PM local time of applicant organization.
AIDS Application Due Date(s)
New, Renewal, Resubmission, and Revision AIDS Applications: May 14, 2018; September 13; 2018; January 11, 2019; May 13, 2019; September 13, 2019, by 5:00 PM local time of applicant organization.
Section II. Award Information
Application Types Allowed
New
Renewal
Resubmission
Revision
Section V. Application Review Information
1. Criteria
Renewals
For Renewals, the committee will consider the progress made in the last funding period.
Modified to read (changes in italics):
Part 1. Overview Information
Key Dates
Application Due Date(s)
New and Revision Applications: February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019, by 5:00 PM local time of applicant organization.
AIDS Application Due Date(s)
New, Resubmission, and Revision AIDS Applications: May 14, 2018; September 13; 2018; January 11, 2019; May 13, 2019; September 13, 2019, by 5:00 PM local time of applicant organization.
Section II. Award Information
Application Types Allowed
New
Resubmission
Revision
Section V. Application Review Information
1. Criteria
Renewals
Not applicable
Inquiries
Please direct all inquiries to:
Keary A. Cope, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email: [email protected]
and Human Services (HHS)
